AL
Annalisa Lattanzi
Research areas: Biochemistry, Genetics and Molecular Biology · Molecular Biology · Virus-based gene therapy research · CRISPR and Genetic Engineering · Hemoglobinopathies and Related Disorders
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (10)
- Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease Save
- Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements Save
- Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus Save
- Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System Save
- Efficacy and biodistribution analysis of intracerebroventricular administration of an optimized scAAV9-SMN1 vector in a mouse model of spinal muscular atrophy Save
- Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe-affected non-human primates by intracerebral lentiviral gene therapy Save
- Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy Save
- Dynamic Activity of miR-125b and miR-93 during Murine Neural Stem Cell Differentiation In Vitro and in the Subventricular Zone Neurogenic Niche Save
- Widespread enzymatic correction of CNS tissues by a single intracerebral injection of therapeutic lentiviral vector in leukodystrophy mouse models Save
- Specific determination of β-galactocerebrosidase activity via competitive inhibition of β-galactosidase Save